Delaware Street Capital

Active

Updated: Apr 2, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Feb 25, 2015	Neos Therapeutics	$20.6M Other Equity	—	Burrill Life Sciences Capital Fund III, CAC, Crabtree Partners, Essex Capital Corporation, Presidio Partners
Mar 4, 2014	Neos Therapeutics	$15.5M Series C	—	Burrill Life Sciences Capital Fund III, CAC, CMEA Capital, Crabtree Partners

Total Raised

N/A

Valuation

N/A